Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Thiosulfate for Pain in Calcific Uremic Arteriolopathy
NCT02527213Phase 3Withdrawn
- Sponsor
- American Regent, Inc.
- Start
- Jan 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium thiosulfate in calcific uremic arteriolopathy (CUA), sponsored by American Regent, Inc.. Planned start Jan 2015; status: withdrawn.
02
Drugs
sodium thiosulfate
03
Conditions
calcific uremic arteriolopathy (CUA)
Beyond the preview
Go deeper on NCT02527213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527213.